Last reviewed · How we verify
10 day concomitant regimen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
10 day concomitant regimen (10 day concomitant regimen) — Alexandra Hospital, Athens, Greece.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 10 day concomitant regimen TARGET | 10 day concomitant regimen | Alexandra Hospital, Athens, Greece | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 10 day concomitant regimen CI watch — RSS
- 10 day concomitant regimen CI watch — Atom
- 10 day concomitant regimen CI watch — JSON
- 10 day concomitant regimen alone — RSS
Cite this brief
Drug Landscape (2026). 10 day concomitant regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/10-day-concomitant-regimen. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing